MAX
Puma Biotechnology, Inc.
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
10/10
|
5.08 | 33.29 | -84.75% | 41.17 | -87.67% |
| P/S |
|
0.67 | 129.32 | -99.48% |
|
|
| P/BV |
|
1.67 | 254.5 | -99.34% |
|
|
| P/FCF |
|
6.56 | -175.34 | -103.74% |
|
|
| Ev/Ebitda |
|
3.3 | -27.64 | -111.93% |
|
|
| Ev/S |
|
0.69 | 535.9 | -99.87% |
|
|
| Ev/FCF |
|
4.08 | -282.58 | -101.44% |
|
|
| E/P |
|
0.12 | 0.0225 | 434.44% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
7/10
|
20.86 | -367.1 | -105.68% | 18.39 | +13.44% |
| ROE |
|
41.6 | 104.5 | -60.19% |
|
|
| ROA |
|
13.64 | -2.18 | -726.93% |
|
|
| ROIC |
|
-32.16 | 1.04 | -3202.25% |
|
|
| ROS |
|
13.44 | -151.96 | -108.84% |
|
|
| ROCE |
|
39.68 | 3.45 | 1048.81% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
7/10
|
1.54 | 1.1 | 40.63% | 2.48 | -37.96% |
| Nеt Debt/Ebitda |
|
0.1 | 1.17 | -91.36% |
|
|
| Debt/Ratio |
|
0.35 | 0.19 | 80.21% |
|
|
| Debt/Equity |
|
1.32 | 1.62 | -18.56% |
|
|
| Debt/Net Income |
|
2.45 | -1.32 | -285.61% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
0/10
|
0 | 0.54 | -100% | 0 | 0% |
| Number of years of dividend growth |
|
0 | 0.98 | -100% | ||
| DSI |
|
0 | 0.23 | -100% |
|
|
| Average dividend growth |
|
0 | 4 | -100% |
|
|
| Average percentage for 5 years |
|
0 | 0.5 | -100% |
|
|
| Average percentage for payments |
|
0 | 57.47 | -100% |
|
|
| Difference from average difference in sector |
|
-0.54 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
1/10
|
2.38 | -54.61 | -104.36% | ||
| Growth impulse Ebitda in 5 years |
|
-262.97 | -92 | 185.84% | ||
| Growth impulse Net Income in 5 years |
|
-150.46 | -77.77 | 93.47% | ||
| Growth impulse FCF in 5 years |
|
-302.41 | -88.99 | 239.82% | ||
| Growth impulse EPS in 5 years |
|
-140.57 | -28.04 | 401.32% |
IP Score
4.74/10
